2m 2m 2m 2m 2m 2m 2m
Akebia Therapeut (AKBA)
NASDAQ
$1.33+$0.005 (+0.38%)
Price as of Aug 03, 2026 10:23 AM EDT- $354.1MMarket Cap
- -64.52%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Akebia Therapeut (AKBA)
$1.33+$0.005 (+0.38%)
Earnings Score
Valuation | AKBA | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | AKBA | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -14.79% | ||
12-Month Momentum | -67.16% | ||
3-Month Risk Adjusted Momentum | -41.09% | ||
12-Month Risk Adjusted Momentum | -90.53% |
True Yield
Valuation | AKBA | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 1.88% |
Financial Health Score
Valuation | AKBA | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |